Navigation Links
ABAXIS Announces Launch of Two New Products at the NAVC
Date:1/16/2009

Company will launch the VetScan(R) VSpro Coagulation Analyzer and VetScan Canine Heartworm Rapid Test at the largest Veterinary Conference in North America

UNION CITY, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis instruments for both the medical and veterinary markets, announced today that it will launch the VetScan VSpro Coagulation Analyzer and VetScan Canine Heartworm Rapid Test at the North American Veterinary Conference in Orlando, Florida on Sunday, January 18th. This conference draws veterinarians and veterinary technicians from around the world, and it is expected that over 7,000 veterinary professionals will be in attendance.

The VetScan Canine Heartworm rapid test is expected to be the first in a series of rapid, lateral flow tests to be released by Abaxis. The test will provide a simple, accurate, and highly cost-effective option for veterinarians to use for their heartworm testing. The US heartworm market is believed to be greater than $70 million per year.

The VetScan VSpro Coagulation Analyzer will allow veterinarians to evaluate PT and aPTT results using a state-of-the-art, in-house / point of care technology. The analyzer will be used in combination with a sophisticated, micro-fluidic technology based cartridge that contains all the reagents necessary to perform PT and aPTT testing. The VetScan VSpro can be combined with the Abaxis VetScan Chemistry and VetScan Hematology instruments to provide veterinarians with a complete clinical picture for critically ill patients, pre-surgical work-ups and for routine wellness exams.

Martin Mulroy, Vice President Sales and Marketing commented "We are very excited to add these two new products to the Abaxis product portfolio.
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd.
2. Abaxis, Inc. to Present at Sidoti & Companys Sixth Annual Palm Beach Emerging Growth Institutional Investor Forum
3. Abaxis, Inc. to Present at Needham & Companys Eleventh Annual Growth Stock Conference
4. Abaxis Point-of-Care Test Panels Gain FDA CLIA-Waived Status
5. Abaxis, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
6. Abaxis to Report Second Quarter Fiscal 2009 Financial Results Monday, October 27, 2008
7. Abaxis, Inc. to Present at CL Kings Sixth Annual Best Ideas Conference
8. Abaxis, Inc. CEO to Present at the Eighth Annual Forbes Global CEO Conference in Singapore
9. Abaxis to Report First Quarter Fiscal 2009 Financial Results Thursday, July 24, 2008
10. Abaxis to Present at the SunTrust Robinson Humphreys 37th Annual Institutional Unconference
11. Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... A team of Kendall Hunt authors earned the ...d at the recent National Association for Gifted Ch...ember 5-7, 2009. , Dubuqu...l Hunt authors earned the 2009 Gifted Child Quarte... Association for Gifted Children’s annual co...
(Date:12/2/2009)...TA, Dec. 2 In response to rising s... FamilyLife, a non-profit ministry dedicated to su... Weekend to Remember® marriage conference at...anta from Dec. 11 - 13 at the Grand Hyatt Atlanta ... Remember is a marriage getaway aimed at strength...
(Date:12/2/2009)...illion - 4 State Campaign Features Small Business ...esses and Would Kill Jobs ,, WASHINGTON, Dec. ...e jobs summit scheduled for Thursday, Keeping Smal... Liberty, today announced a new $1 million 4 state...of the current health care legislation on small bu...
(Date:12/2/2009)...S ANGELES, Dec. 2 At a ...Tourism ministerial delegates came together to out...equired to give it the necessary thrust. Organized...edicaltourismassociation.com , the high-powered co...iscussed the opportunities and requests for assist...
(Date:12/2/2009)..., KANSAS CITY, Mo., Dec. 2 Lock...omprehensive, practical view on proposed health re... (Logo: http://www.newscom.com/cgi-bin/prnh/20090...od, bad, and ugly in the legislation, according to...on Benefit Group,s Compliance Services Division ...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:FamilyLife Supports Military Marriages in Atlanta 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 2Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 3Health News:With White House Jobs Summit This Week KSBH Unveils New TV Ads Targeting Senators on Health Care 4Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Lockton Outlines Implications of Proposed Health Reform Plans 2
... Students and Professors Honored for Their Researc... 12,outstanding Ph.D. students and two professors ...or research accomplishments in the field of organi...c,chemistry in pharmaceutical discovery. This year...
... 14 On Sunday, June 29,2008, West Coast Bank will... (ALAO) Reach the Bridge Run, Portland,s most uniq...choose their own start times, but must reach the,B...roads of Forest Park., West Coast Bank Relationsh...
...r of the International Association of Business Com...n of The University of Texas Medical School at Hou...prestigious award was given April 24 at the organi...nce in leadership , management, and communication ...
...heKnows.com,( http://www.SheKnows.com ), one of th...nnounced today the acquisition of PregnancyandBaby... online community for women from,preconception thr...offers a,comprehensive collection of articles, int...
...equired for Immediate Needs, NEW YORK, May 14 Tw...n a generation, news of its full impact on the,com...ickling in at a,painfully slow speed., According ...f villages and small towns were almost completely ...
...eadings rise, urges broader public action to curb ...ews) -- Just a few hours of exposure to particulat... and harm blood vessel function within 24 hours, a...roke, the researchers said. , Particulate matter (...
Other Medicine News:Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 2Health News:Roche Symposium Showcases Accomplishments of Next Generation of Chemists 3Health News:UT Houston Dean Colasurdo named Executive Communicator of the Year 2Health News:SheKnows Acquires PregnancyandBaby - Online Community From Preconception Through Birth 2Health News:UNICEF Rushing Medical Supplies, Tents, Clean Water to Children Affected by Powerful Earthquake in China 2Health News:Pollution Particles Impair Blood Vessel Function 2
(Date:12/1/2009)...RK, Dec. 1 Reportlinker.com announ... in its catalogue: ,, Medical Oxygen Systems ...reportlinker.com/p0164334/Medical-Oxygen-Systems--... medical oxygen systems market for home healthcare...s. The buoyant growth expectations stem from demog...
(Date:12/1/2009)...N.J., Dec. 1 Johnson & Johnson... announced today that it has submitted a New Drug ...stration (FDA) for tapentadol extended release (ER...he management of moderate to severe chronic pain i...c pain, defined as pain that persists for long per...
(Date:12/1/2009)...STATION, N.J., Dec. 1 Merck & ...rug Administration (FDA) has approved ZEGERID OTC(...apsules), for over-the-counter treatment of freque...he-counter by Schering-Plough HealthCare Products,...amp; Co., Inc. Schering-Plough and Merck merged on...
Breaking Medicine Technology:Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 2New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 3New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 4New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 5New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 6New Drug Application Submitted to FDA for Tapentadol Extended Release Tablets for Management of Chronic Pain 7FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Interventional radiology resources cover peripheral arterial disease 56584 1Interventional radiology resources cover peripheral arterial disease 56584 2Interventional radiology resources cover peripheral arterial disease 56584 3Toward a nanomedicine for brain cancer 9839 1ACLA Opposes Proposed LabTax 56582 1ACLA Opposes Proposed LabTax 56582 2
... by Medical Research Council, LEXINGTON, Mass., A...EV ) announced today the completion of,enrollment ... PRO 2000, the,Company,s candidate vaginal microbi...transmitted infections. The trial is sponsored by ...) and conducted by the Microbicides,Development Pr...
...ciences, Inc. (Nasdaq: HGSI ) today announced tha...ng of patients in a randomized Phase 2 trial of,HG...therapy agents,paclitaxel and carboplatin as first...er (NSCLC)., (Logo: http://www.newscom.com/cgi-b...medical need for effective treatment options for,n...
Other Medicine Technology:Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 2Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 3Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 4Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000 5Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: